This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Sprycel
  • /
  • A Phase II Study of Dasatinib in Children and Adol...
Clinical trial

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Read time: 3 mins
Last updated:19th Feb 2009
Identifier: NCT00777036
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest